Trademark: 79141948
Status Date
Friday, February 11, 2022
Registration Number
4779408
Registration Date
Tuesday, July 28, 2015
Filing Date
Friday, November 15, 2013
Published for Opposition
Tuesday, May 12, 2015
Cancellation Date
Friday, February 11, 2022
40 Custom manufacture of pharmaceuticals
5 Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; Pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; Pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; Pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; Pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; Pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; Pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; Pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; Pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; Pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; Pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; Pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; Pharmaceutical preparations for use in connection with humans for the prevention of mental disorders ; Pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; Pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; Pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; Pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; Pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; Pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; Pharmaceutical preparations for use in connection with humans for the treatment of deformations; Pharmaceutical preparations for use in connection with humans for the prevention of deformations; Pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; Pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; Prescribed pharmaceutical preparations for the treatment of infectious diseases; Prescribed pharmaceutical preparations for the prevention of infectious diseases; Prescribed pharmaceutical preparations for the treatment of parasitic diseases; Prescribed pharmaceutical preparations for the prevention of parasitic diseases; Prescribed pharmaceutical preparations for the treatment of neoplasms; Prescribed pharmaceutical preparations for the prevention of neoplasms; Prescribed pharmaceutical preparations for the treatment of diseases of the blood; Prescribed pharmaceutical preparations for the prevention of diseases of the blood Prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; Prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; Prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; Prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; Prescribed pharmaceutical preparations for the treatment of endocrine diseases; Prescribed pharmaceutical preparations for the prevention of endocrine diseases; Prescribed pharmaceutical preparations for the treatment of nutritional diseases; Prescribed pharmaceutical preparations for the prevention of nutritional diseases; Prescribed pharmaceutical preparations for the treatment of metabolic diseases; Prescribed pharmaceutical preparations for the prevention of metabolic diseases; Prescribed pharmaceutical preparations for the treatment of mental disorders; Prescribed pharmaceutical preparations for the prevention of mental disorders; Prescribed pharmaceutical preparations for the treatment of behavioural disorders; Prescribed pharmaceutical preparations for the prevention of behavioural disorders; Prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; Prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; Prescribed pharmaceutical preparations for the treatment of diseases of the eye; Prescribed pharmaceutical preparations for the prevention of diseases of the eye; Prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; Prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; Prescribed pharmaceutical preparations for the treatment of diseases of the ear; Prescribed pharmaceutical preparations for the prevention of diseases of the ear; Prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; Prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; Prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; Prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; Prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; Prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; Prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; Prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; Prescribed pharmaceutical preparations for the treatment of diseases of the skin; Prescribed pharmaceutical preparations for the prevention of diseases of the skin; Prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; Prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; Prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; Prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; Prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; Prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; Prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; Prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; Prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; Prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; Prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; Prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; Prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; Prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; Prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; Prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; Prescribed pharmaceutical preparations for the treatment of congenital malformations; Prescribed pharmaceutical preparations for the prevention of congenital malformations; Prescribed pharmaceutical preparations for the treatment of deformations; Prescribed pharmaceutical preparations for the prevention of deformations; Prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; Prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; Biological pharmaceutical preparations for the treatment of infectious diseases; Biological pharmaceutical preparations for the prevention of infectious diseases; Biological pharmaceutical preparations for the treatment of parasitic diseases; Biological pharmaceutical preparations for the prevention of parasitic diseases; Biological pharmaceutical preparations for the treatment of neoplasms; Biological pharmaceutical preparations for the prevention of neoplasms; Biological pharmaceutical preparations for the treatment of diseases of the blood; Biological pharmaceutical preparations for the prevention of diseases of the blood; Biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; Biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; Biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; Biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; Biological pharmaceutical preparations for the treatment of endocrine diseases; Biological pharmaceutical preparations for the prevention of endocrine diseases; Biological pharmaceutical preparations for the treatment of nutritional diseases; Biological pharmaceutical preparations for the prevention of nutritional diseases; Biological pharmaceutical preparations for the treatment of metabolic diseases; Biological pharmaceutical preparations for the prevention of metabolic diseases; Biological pharmaceutical preparations for the treatment of mental disorders; Biological pharmaceutical preparations for the prevention of mental disorders; Biological pharmaceutical preparations for the treatment of behavioural disorders; Biological pharmaceutical preparations for the prevention of behavioural disorders; Biological pharmaceutical preparations for the treatment of diseases of the nervous system; Biological pharmaceutical preparations for the prevention of diseases of the nervous system; Biological pharmaceutical preparations for the treatment of diseases of the eye; Biological pharmaceutical preparations for the prevention of diseases of the eye; Biological pharmaceutical preparations for the treatment of diseases of eye adnexa; Biological pharmaceutical preparations for the prevention of diseases of eye adnexa; Biological pharmaceutical preparations for the treatment of diseases of the ear; Biological pharmaceutical preparations for the prevention of diseases of the ear; Biological pharmaceutical preparations for the treatment of diseases of the mastoid process; Biological pharmaceutical preparations for the prevention of diseases of the mastoid process; Biological pharmaceutical preparations for the treatment of diseases of the circulatory system; Biological pharmaceutical preparations for the prevention of diseases of the circulatory system; Biological pharmaceutical preparations for the treatment of diseases of the respiratory system; Biological pharmaceutical preparations for the prevention of diseases of the respiratory system; Biological pharmaceutical preparations for the treatment of diseases of the digestive system; Biological pharmaceutical preparations for the prevention of diseases of the digestive system; Biological pharmaceutical preparations for the treatment of diseases of the skin; Biological pharmaceutical preparations for the prevention of diseases of the skin; Biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; Biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; Biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; Biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; Biological pharmaceutical preparations for the treatment of diseases of the connective tissue; Biological pharmaceutical preparations for the prevention of diseases of the connective tissue; Biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; Biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; Biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; Biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; Biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; Biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; Biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; Biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; Biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; Biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; Biological pharmaceutical preparations for the treatment of congenital malformations; Biological pharmaceutical preparations for the prevention of congenital malformations; Biological pharmaceutical preparations for the treatment of deformations; Biological pharmaceutical preparations for the prevention of deformations; Biological pharmaceutical preparations for the treatment of chromosomal abnormalities; Biological pharmaceutical preparations for the prevention of chromosomal abnormalities;bandages for dressings
35 Providing information concerning commercial sales in the field of pharmaceuticals
44 Pharmaceutical information services provided via the Internet, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information
10 Apparatus for drug administration, namely, drug delivery systems, injector, autoinjector; Therapeutic inhalers, sold empty; High frequency electromagnetic therapy apparatus; Oxygen inhalaters for therapeutic purposes; Ultraviolet radiator units for therapeutic purposes; Defibrillators; Pneumothorax apparatus, namely, medical apparatus for diagnosing or treating respiratory conditions; Heart pacemakers; Mercury arc lamp units for therapeutic purposes; Infrared radiator units for therapeutic purposes; Puncture apparatus for therapeutic purposes, namely, medical devices for closing wounds; Lavage apparatus for therapeutic purposes, namely, apparatus for washing out body cavities; Carbon arc lamp units for therapeutic purposes; Injection syringes, syringe barrels; Injection needles; Infusion apparatus for therapeutic purposes, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; Ultrasonic therapy machines and apparatus; Short wave therapy machines and apparatus; Therapeutic bath apparatus and instruments, namely, appliances for washing body cavities; Massage apparatus for medical purposes; Low frequency electric therapy apparatus; Static electric therapy apparatus; Dialyzers, namely, blood component separation apparatus for medical purposes; Acupuncture needles; Sprayers for medical purposes, namely, drug delivery sprayers sold empty; Suture apparatus for medical purposes, namely, suture needles and suture materials; Radioisotope therapy apparatus and instruments; Incubators for babies; Blood transfusion apparatus; Containers and trays specially designed for transporting and holding pharmaceuticals; Injection device for pharmaceuticals; Injection instruments without needles; Injection instruments with needles
42 Pharmaceutical research; pharmaceutical development
Oct 6, 2023
International Registration Renewed
Jun 6, 2023
Final Decision Transaction Processed By Ib
Apr 14, 2023
Generic Madrid Transaction Sent To Ib
Apr 14, 2023
Invalidation Reviewed - No Action Required By Office
Apr 14, 2023
Generic Madrid Transaction Created
Jan 15, 2023
Final Decision Transaction Processed By Ib
Oct 11, 2022
Total Invalidation Of Reg Ext Protection Created
May 30, 2022
Notification Processed By Ib
Mar 21, 2022
Refusal Processed By Ib
Feb 11, 2022
Cancelled Section 71
Jan 31, 2016
Final Decision Transaction Processed By Ib
Dec 15, 2015
Generic Madrid Transaction Sent To Ib
Dec 15, 2015
Generic Madrid Transaction Created
Oct 28, 2015
Final Disposition Notice Created, To Be Sent To Ib
Oct 20, 2015
Correction From Ib Entered - No Review Required
Oct 9, 2015
Correction Transaction Received From Ib
Jul 28, 2015
Registered-Principal Register
Jul 17, 2015
Notification Of Possible Opposition - Processed By Ib
Jul 1, 2015
Notification Of Possible Opposition Sent To Ib
Jul 1, 2015
Notification Of Possible Opposition Created, To Be Sent To Ib
May 12, 2015
Published For Opposition
May 8, 2015
Notification Processed By Ib
Apr 22, 2015
Notification Of Possible Opposition Sent To Ib
Apr 22, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 22, 2015
Notice Of Publication
Apr 7, 2015
Law Office Publication Review Completed
Apr 7, 2015
Assigned To Lie
Mar 20, 2015
Examiners Amendment Mailed
Mar 19, 2015
Approved For Pub - Principal Register
Mar 19, 2015
Examiner's Amendment Entered
Mar 19, 2015
Examiners Amendment -Written
Feb 6, 2015
Final Refusal Mailed
Feb 5, 2015
Final Refusal Written
Jan 16, 2015
Teas/Email Correspondence Entered
Jan 15, 2015
Correspondence Received In Law Office
Jan 15, 2015
Teas Response To Office Action Received
Jul 22, 2014
Non-Final Action Mailed
Jul 21, 2014
Non-Final Action Written
Jun 30, 2014
Teas/Email Correspondence Entered
Jun 30, 2014
Correspondence Received In Law Office
Jun 19, 2014
Assigned To Lie
Jun 11, 2014
Teas Response To Office Action Received
Apr 25, 2014
Refusal Processed By Ib
Mar 25, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Mar 25, 2014
Refusal Processed By Mpu
Mar 25, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Mar 24, 2014
Non-Final Action Written
Mar 24, 2014
Assigned To Examiner
Feb 4, 2014
Application Filing Receipt Mailed
Jan 31, 2014
New Application Office Supplied Data Entered
Jan 30, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
